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Recruitment of maternal mRNA in mice appears essential for embryonic gene activation (EGA) that is initiated in the 1-cell stage. The
identity of which recruited mRNAs is responsible, however, is not known. We report here that recruitment of cyclin A2 mRNA may be
critical for EGA. Cyclin A2 protein accumulates in pronuclei between 6 and 12 h after fertilization, the time when EGA is initiated. This
cyclin A2 may be generated from maternally recruited cyclin A2 mRNA because its accumulation was inhibited by 3V-deoxyadenosine,
which inhibits mRNA polyadenylation. When CDK2 activity or pronuclear accumulation of cyclin A2 was inhibited with CDK2 inhibitors or
by microinjected siRNAs, respectively, DNA replication was not inhibited but the increase of transcriptional activity was prevented. In
addition, microinjection of recombinant cyclin A2-CDK2 protein increased transcriptional activity. Cyclin A2-CDK2 is activated following
egg activation, because an increase in phosphorylation of retinoblastoma protein was observed using antibodies that recognize site-specific
phosphorylation catalyzed by this kinase and treatment with a CDK2 inhibitor or microinjection with cyclin A2 siRNAs prevented the
increase in retinoblastoma protein phosphorylation. These results suggest that recruitment of maternal cyclin A2 mRNA following egg
activation is linked to EGA.
D 2005 Elsevier Inc. All rights reserved.Keywords: Cyclin A2; Cyclin-dependent kinase 2; Embryonic gene activation; 1-Cell mouse embryo; Phosphorylation of retinoblastoma proteinIntroduction
Developing mouse oocytes are transcriptionally active,
but a global decrease in transcription starts around mid-
growth phase such that there is little transcription in the
fully grown oocyte. Following maturation and arrest at
metaphase II, fertilization triggers resumption of meiosis
and activation of the embryonic genome. The timing of
embryonic gene activation (EGA) is species-specific0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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and in mouse is initiated in the 1-cell embryo, several
hours after pronuclear formation (Aoki et al., 1997;
Bounial et al., 1995; Matsumoto et al., 1994; Ram and
Schultz, 1993); the identity of the genes transcribed in the
1-cell embryo, however, is poorly defined. EGA is quite
robust in the 2-cell embryo and is responsible for a major
reprogramming of gene expression that likely provides the
molecular foundation of transforming the highly differ-
entiated oocyte into the totipotent blastomeres of the 2-cell
embryo.
EGA differs from initiation of transcription in somatic
cells following entry into interphase. In somatic cells,
transcription ceases only for a short time during mitosis
and is then rapidly established following entry into86 (2005) 102 – 113
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transcription is absent during the ¨14 h that it takes
oocytes to mature and arrest at metaphase II, a condition
that can be maintained for several additional hours prior to
fertilization. Only when pronuclei have formed (¨5–7 h
post-fertilization) and DNA replication has initiated is
transcription detected, i.e., about 10 h post-fertilization. In
addition, whereas cytokines frequently modulate the gene
expression profile via signal transduction pathways that
converge on the nucleus, the dramatic reprogramming of
gene expression that accompanies EGA only requires egg
activation.
Although successful execution of EGA is essential for
further development, little is known about the molecular
basis that regulates EGA, although 1-cell mouse embryos
have some transcription factors and RNA polymerase II
(RNAP II) activity. For instance, nuclear concentrations of
the transcription factor Sp1 and the TATA-box binding
protein TBP increase during 1-cell stage (Worrad et al.,
1994). Inhibiting phosphorylation of RNAP II subunits
with bisindolylmaleimide I (BIM) in 1-cell embryos is
correlated with a decrease in transcription (Miyara et al.,
2003). In addition, although a transcriptionally permissive
state is established during the 1-cell stage, the factors
responsible for transcription, e.g., RNAP II, are universally
required for gene expression. What is lacking is identifying
specific mechanisms for initiating EGA in 1-cell mouse
embryos.
Cytoplasmic poly(A) tail elongation of maternal mRNA
is tightly coupled with translation of mRNAs and is a central
mechanism for controlling translation of mRNA during
maturation of Xenopus laevis oocytes. Recruitment of
maternal mRNAs also occurs during maturation and
following fertilization of mouse oocytes (Barkoff et al.,
2000; Paynton and Bachvarova, 1994; Tay et al., 2000). For
example, following fertilization, spindlin and cyclin A2
mRNAs undergo poly(A) tail elongation and translation
(Fuchimoto et al., 2001; Oh et al., 2000). Interestingly,
treating 1-cell mouse embryos with 3V-deoxyadenosine,
which functions as a chain terminator of poly(A) tail
elongation of maternal mRNA, but not 3V-deoxyguanosine,
decreases transcriptional activity in 1-cell embryos (Aoki et
al., 2003). This result led to the hypothesis that recruitment
of some maternal mRNAs following fertilization is essential
for EGA. This finding is also consistent with the observa-
tion that protein synthesis is required for EGA (Aoki et al.,
2003; Wang and Latham, 1997; Wang and Latham, 2000).
The identity of the maternal mRNAs recruited and essential
for EGA, however, remains unknown.
Recruitment of maternal cyclin A2 mRNA could be
such an mRNA. The amount of cyclin A2 protein increases
from 6 h to 12 h post-insemination, i.e., when EGA is first
observed in the 1-cell embryo, and translation of cyclin A2
mRNA is inhibited by 3V-deoxyadenosine (Fuchimoto et
al., 2001). In somatic cells, cyclin A2, as well as cyclins D
and E, activate specific cyclin-dependent kinases that inturn phosphorylate retinoblastoma protein (pRB). This
phosphorylation induces conformational changes of pRB
and releases the transcription factor E2F from pRB
complex. Free E2F then directs gene expression involved
in S-phase entry and S-phase progression.
We report here that inhibiting cyclin A2-CDK2 kinase
with either roscovitine or siRNAs directed towards
maternal cyclin A2 mRNA inhibits EGA in 1-cell
embryos, whereas over-expressing cyclin A2-CDK2 leads
to an increase in transcription. Results of these experiments
suggest that recruitment of maternal cyclin A2 mRNA
following fertilization leads to CDK2 activation that in turn
triggers EGA in the 1-cell mouse embryo.Materials and methods
In vitro fertilization and embryo culture
Female ddY mice, 21–23 days of age and mature ICR
male mice were purchased from SLC Japan Inc. (Shizuoka,
Japan). Metaphase II-arrested eggs (MII eggs) were
obtained following superovulation of female mice with 5
IU of pregnant mare’s serum gonadotrophin (Teikoku
zouki, Tokyo, Japan) followed 48 h later by 5 IU of
human chorionic gonadotrophin (hCG) (Teikoku zouki).
MII eggs embedded in cumulus cell masses were isolated
from the ampullae of oviducts 15.5 h post-hCG injection
and kept in Whitten’s medium (Whitten, 1971). Sperm
obtained from the cauda epididymis of ICR male mice and
incubated for 2 h in Whitten’s medium in a humidified
atmosphere of 5% CO2/95% air at 38-C were used for
fertilization in vitro. Six hours after insemination, fertilized
eggs were identified as those containing a male and female
pronucleus and washed three times prior to culture in
glucose-free CZB medium (Chatot et al., 1989). When
zona pellucida-free eggs were used, the zona pellucida
was removed by a brief treatment in acidic Minimum
Essential Medium-compatible buffer (Acidic-MEMCO)
(Evans et al., 1995a,b).
Treatment of embryos with CDK2 inhibitors and other
inhibitors
Four hours after insemination, the embryos were trans-
ferred to Whitten’s medium containing 250 Ag/ml of
hyaluronidase (Sigma-Aldrich Co., St. Louis, MO, USA)
and incubated for 5 min at 37-C to remove cumulus cells.
After washing three times in glucose-free CZB medium,
the embryos were transferred to glucose-free CZB medium
containing 100 AM of butyrolactone I (Wako Pure
Chemical Industries, Ltd., Osaka, Japan) or 100 AM
of roscovitine (Sigma-Aldrich Co.). The embryos were
cultured until 12 h post insemination at which time they
were used for either the in vitro transcription assay or
immunocytochemistry. When embryos were treated with
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Co.), cycloheximide (10 Ag/ml, Sigma-Aldrich Co.), 3V-
deoxyadenosine (2 mM, Sigma Chemical Co., St. Louis,
MO, USA), or 3V-deoxyguanosine (2 mM, Sigma Chemical
Co.), they were collected 1 h after insemination and
transferred to glucose-free CZB medium containing these
chemicals.
In vitro transcription assay
In vitro transcriptional activity assays were conducted as
previously described (Kim et al., 2002). Briefly, 1-cell
mouse embryos, whose plasma membrane had been
permeabilized with Triton X-100, were incubated with
BrUTP. The amount of incorporated BrU was measured
by immunostaining with a primary antibody recognizing
BrU (Roche Diagnostics Co., Indianapolis, IN, USA) and an
FITC-conjugated secondary antibody. The intensity of the
fluorescence signal was quantified using NIH-Image soft-
ware (National Institute of Health, Bethesda, MD, USA).
The relative amount of fluorescence in both the male and
female pronuclei was combined in each embryo.
Immunoblotting
Immunoblotting was performed as described previously
(Fuchimoto et al., 2001). Briefly, two hundred MII eggs and
1-cell embryos collected 12 h after insemination were
subjected to SDS-PAGE (10% gel) and then transferred to a
polyvinylidene difluoride (PVDF) membrane. The primary
and secondary antibodies used for the detection of CDK2
were an anti-cdk2 antibody (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA; catalog number sc-163) and
anti-rabbit Ig, horseradish peroxidase-linked antibody
(Amersham Biosciences, Buckinghamshire, UK; catalog
number NA934V), respectively.
Immunostaining
Eggs and 1-cell embryos were immunostained as
described previously (Kim et al., 2002), except for the
following changes. The zona pellucida was removed using
acidic-MEMCO before fixation as previously described
(Evans et al., 1995a,b). Primary antibodies used were as
follows: pRB, Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA; catalog number sc-50; phosphorylated Ser780
of pRB, Cell Signaling Technology Inc., Beverly, MA,
USA; catalog number 9307; phosphorylated Ser249/
Thr252, Thr356, Ser807/811, Thr821/826 of pRB, Santa
Cruz Biotechnology, Inc.; catalog numbers sc-16671, sc-
16837, sc-16670, and sc-16669, respectively; TFIID (TBP)
and cyclin A2, Santa Cruz Biotechnology, Inc.; catalog
numbers sc-204 and sc-751, respectively. To prepare
working solutions of the primary antibodies, each antibody
was diluted 1:100 with PBS/BSA. The embryos were
incubated with each antibody for 1 h at room temperature,except for anti-cyclin A2 antibody, in which the incubation
was performed overnight at 4-C. The fluorescence of the
secondary FITC-conjugated antibody was detected using a
Carl Zeiss 510 laser-scanning confocal microscope. The
intensity of fluorescence was quantified using NIH-Image
as described above.
Detection of DNA synthesis
DNA synthesis was detected by 5-bromo-2V-deoxyuri-
dine (BrdU) incorporation as previously described (Aoki
and Schultz, 1999). The embryos were collected 9 h after
insemination, transferred to glucose-free CZB medium
containing 10 AM of BrdU (Roche Diagnostics Co.), and
incubated for 1 h at 37-C in CO2 incubator. After HCl
treatment, the embryos were subjected to immunostaining
with 2 Ag/ml of anti-BrdU monoclonal antibody (Roche
Diagnostics Co.) for 1 h at room temperature and
processed for laser-scanning confocal microscopy as
described above.
Microinjection of cyclin A2-CDK2 protein into 1-cell
embryos
Eggs were collected 1 h after insemination in vitro and
used for microinjection. Microinjection was performed
with an inverted microscope (ECLIPSE TE300, Nikon Co.,
Tokyo, Japan) using a micromanipulator (Narishige Co.,
Ltd., Tokyo, Japan) and microinjector (IM300, Narishige
Co., Ltd.). After washing three times in Whitten’s medium,
10–20 pl of cyclin A2-CDK2 active protein (0.2 Ag/Al)
(Upstate Biotechnology, Lake Placid, NY, USA; catalog
number 14-448) was injected using borosilicate glass
capillaries (GC100 TF-10, Harvard Apparatus Ltd., Kent,
UK); heat-inactivated protein was used as the control. The
injected embryos were cultured in glucose-free CZB
medium, collected 6 h and 10 h after insemination, and
subjected to immunostaining or in vitro transcriptional
activity assay.
Cloning of mouse cyclin A2
Total mRNA was isolated from two hundred MII eggs
using ISOGEN (Nippon Gene, Tokyo, Japan) according to
the manufacturer’s instructions. Isolated mRNAs were
reverse-transcribed in a 21-Al reaction mixture containing
1 Al of oligo (dT) primer (500 mg/ml, GIBCO BRL, Boston,
MA, USA), 4 Al of 5 reaction buffer, 2 Al of DTT (0.1 M),
1 Al of dNTP mixture (four nucleotides, each at a
concentration of 10 mM, GIBCO BRL), 1 Al of RNasin
(40 units/ml, Promega Co.), and 10 units of Super Script II
RNase H-Reverse Transcriptase (GIBCO BRL) at 42-C for
50 min.
Amplification of cyclin A2 cDNA by PCR was carried
out in a 25-Al reaction mixture containing 2.5 Al of  10
PCR reaction buffer, 1.5 Al of 25 mM MgCl2, 2.5 Al of 2.5
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1.25 units of Ampli Taq Gold DNA polymerase (Applied
Biosystems, Foster City, CA, USA), and 2 Al of cDNA
solution. The following primers were used: mouse cyclin
A2 sense primer, 5V-CCG CGA TGC CGG GCA CCT-3V;
mouse cyclin A2 antisense primer, 5V-TCA CAC ACT TAG
TGT CTC TG-3V. The samples were heated at 95-C for 10
min and 40 cycles of PCR were performed as follows:
denaturation at 95-C for 30 s, annealing at 60-C for 30 s,
extension at 72-C for 60 s, and a final extension at 72-C for
10 min. The amplified products were separated on 2%
agarose gel electrophoresis and visualized by staining with
ethidium bromide. The band of the anticipated size (1237
bp) was cut out, the cDNA fragments were eluted and
subcloned into a pCR II vector (Invitrogen Co., Carlsbad,
CA, USA). DNA sequences were determined by the
dideoxy method using the DNA sequencing system of
Applied Biosystems Japan Ltd., Tokyo.
Preparation of diced siRNA (d-siRNA)
Small interfering RNA (siRNA) was prepared by dicing
mouse cyclin A2 double-strand RNA (dsRNA). A pCR II
plasmid containing the whole coding region of cyclin A2
was used as a template for Pfu DNA polymerase (Promega
Co.) and cyclin A2 sense/antisense primers. PCR con-
ditions were as follows: Following an initial heat treatment
at 95-C for 1 min, PCR was performed for 15 cycles
consisting of a denaturation step at 95-C for 30 s,
annealing at 60-C for 30 s, extension at 72-C for 90 s,
and a final extension at 72-C for 10 min. The amplified
cDNA product was separated on 2% agarose gel electro-
phoresis and visualized. The product of the appropriate size
(1237 bp) was cut out, and the cDNA fragments were
eluted. This PCR product was then amplified in a second
PCR reaction using Pfu DNA polymerase and the
following primers: cyclin A2 T7-sense primer, 5V-TAA
TAC GAC TCA CTA TAG GTA CTC CGC GAT GCC
GGG CAC CT-3V; cyclin A2 T7-antisense primer, 5V-TAA
TAC GAC TCA CTA TAG GTA CTT CAC ACA CTT
AGT GTC TCT G-3V. The second PCR was performed
through 25 cycles using the same conditions as in the first
PCR reaction.
Both the cyclin A2 sense RNA and antisense RNA were
transcribed from the purified second PCR product. In vitro
transcription was performed in a 20-Al reaction mixture
containing 2 Al of 10 reaction buffer, 2 Al of 10 mM
NTP mixture, 40 units of RNasin (Promega Co.), 1 Ag of
the PCR product, and 20 units of T7 RNA polymerase
(Roche Diagnostics GmbH, Mannheim, Germany) for 1 h
at 37-C. RNase-free DNase I (20 units, Roche Diagnostics
GmbH) was added, the sample incubated 30 min at 37-C,
and the reaction terminated by adding 2 Al of 0.2 M
EDTA. The single-strand RNAs (ssRNAs) were harvested
by ethanol precipitation, resuspended, and 60 Ag of
ssRNAs was added to an RNase-free microcentrifuge tube.The tube was transferred to 250 ml of boiled water and left
for 1–1.5 h to allow re-annealing and formation of
dsRNA, which was ‘‘diced’’ using the BLOCK-iTi Dicer
RNAi Kits (Invitrogen Co.). The dsRNA (60 Ag) was
diced to siRNA in a 300-Al reaction mixture containing
reaction buffer and 60 units of dicer enzyme for 16 h at
37-C. siRNA production was confirmed following electro-
phoresis in a 4% agarose gel stained with ethidium
bromide and containing 10-bp DNA step ladder markers
(Promega Co.). The diced siRNAs (d-siRNA) were then
purified using the BLOCK-iTi RNAi purification
reagents and spin cartridges were supplied with BLOCK-
iTi kit (Invitrogen Co.). The purified d-siRNA was
injected to MII eggs as described below.
d-siRNA against rabbit alpha-globin was prepared as a
control. The cDNA of rabbit alpha globin was obtained by
reverse transcription of the mRNA (Sigma Chemical Co.)
and amplified with Pfu DNA polymerase (Promega Co.)
using the following primers: globin sense primer, 5V-CCC
GCT GAC AAG ACC AAC AT-3V and globin antisense
primer, 5V-CGA TAT TTG GAG GTC AGC AC-3V. PCR
was performed for 15 cycles consisting of denaturation at
95-C for 30 s, annealing at 58-C for 30 s, extension at
72-C for 45 s, and a final extension at 72-C for 5 min. The
band of the expected size (413 bp) was excised, and the
cDNA fragments were subjected to another round of PCR
(25 cycles) using Pfu DNA polymerase and following
primers: Globin T7-sense primer, 5V-TAA TAC GAC TCA
CTATAG GTA CTC CCG CTG ACA AGA CCA ACAT-
3V; Globin T7-antisense primer, 5V-TAA TAC GAC TCA
CTA TAG GTA CTC GAT ATT TGG AGG TCA GCA C-
3V. In vitro transcription and dicing reaction were performed
as for cyclin A2.
Microinjection of d-siRNA into MII stage oocytes
MII eggs 15.5 h post-hCG injection were used for
microinjection. Microinjection was performed essentially as
described above except that the micropipette was held with
a microelectrode holder (World Precision Instruments, Inc.,
Sarasota, FL, USA; catalog number MEH7W10) that is
designed to provide an electrical coupling between d-siRNA
solution-filled glass pipettes and high input impedance
microelectrode amplifiers (Nihon Kohden Co., Tokyo,
Japan; catalog number MEZ-8301). High input impedance
induced the penetration of leading edge of capillary into
zona pellucida and cell membrane and resulted in a high
incidence of survival and fertilization: more than 60% of
microinjected oocytes formed a pronucleus 6 h after
insemination (511/787; 64.9%).
Metabolic labeling of the embryos with [35S] methionine
Embryos were collected 10 h after insemination,
transferred to CZB medium containing 1 mCi/ml of
[35S] methionine (Amersham Pharmacia Biotech UK
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radiolabeled for 2 h at 37-C in a humidified atmosphere
of 5% CO2/95% air. Acid insoluble radioactivity was then
measured as previously described (Fuchimoto et al.,
2001).
Statistical analysis
Statistical analysis was performed using Student’s t test
with a P value of <0.01 as being significant.Results
Effects of 3V-deoxyadenosine and cycloheximide on
pronuclear accumulation of cyclin A2
We previously reported that although cyclin A2 protein is
not detected in eggs, it is detected following fertilization.
Moreover, the increase in amount that occurs following
fertilization is inhibited by 3V-deoxyadenosine (3-dA), an
inhibitor of mRNA polyadenylation (Fuchimoto et al.,
2001). What was not determined was its localization, which
is important because cyclin A2 functions in the nucleus
(Jackman et al., 2002; Pines and Hunter, 1991). EGA
initiates at mid-S phase (Aoki et al., 1997) and hence we
used immunostaining to localize cyclin A2 in 1-cell embryos
collected 6 and 12 h post-insemination when the embryos are
in G1 and S/G2, respectively (Fig. 1; Aoki et al., 1992; Aoki
and Schultz, 1999). We also confirmed that no BrUTP
incorporation was detected at 6 h, detected in a very small
fraction of the embryos labeled at 8 h, and in all of the
embryos labeled at 12 h (data not shown). Immunostaining
showed that the amount of cyclin A2 was clearly enriched in
the pronuclei, and increased between 6 and 12 h following
fertilization (Fig. 2).
To ascertain whether nuclear accumulation of cyclin A2
was due to recruitment of maternal cyclin A2 mRNA, 1-cell
embryos were cultured in the presence of 3-dA or cyclo-
heximide (CHX). Both treatments inhibited pronuclear
accumulation (Fig. 2). The 3-dA effect was specific because
the effect of 3V-deoxyguanosine (3-dG) treatment was
substantially less than that observed with 3-dA. The
inhibitory effect of 3-dA accumulation is consistent with
previous results that employed immunoblotting (FuchimotoFig. 1. Timing of cell cycle events in the 1-cell mouse embryo.et al., 2001) and support the hypothesis that maternal cyclin
A2 mRNA is polyadenylated and translated after fertiliza-
tion. In somatic cells, newly synthesized cyclin A2 can bind
to existing CDK2, and formation of the heterodimer permits
nuclear accumulation (Jackman et al., 2002; Maridor et al.,
1993). Results of immunoblotting experiments revealed that
CDK2 is already present in the egg and that its mass doesn’t
increase following fertilization (Supplemental Fig. 1).
Therefore, like somatic cells, the newly synthesized cyclin
A2 may initiate nuclear accumulation of the cyclin A2-
CDK2 complex (Jackman et al., 2002; Maridor et al.,
1993).
Effects of CDK2 inhibitors and the microinjection of cyclin
A2 diced siRNA or cyclin A2-CDK2 protein on EGA
To examine whether the cyclin A2-CDK2 complex is
involved in regulating EGA, 1-cell embryos were cultured
in the presence of roscovitine (Ros) or butyrolactone I
(BL1), potent CDK inhibitors. The presence of these
inhibitors resulted in a marked decrease in transcriptional
activity when assayed 12 h post-insemination (Fig. 3).
These results suggested that cyclin A2-CDK2 regulates
initiation of EGA. Note that fertilization triggers a rapid
and dramatic decrease in cyclin B-CDK1 activity, which is
essentially negligible 12 h post-insemination (Choi et al.,
1991). Thus, it was unlikely that the observed effects of
these inhibitors could be attributed to inhibiting CDK1. It
was also unlikely that the effects were due to the
inhibition of CDK4 or CDK6, because their expression
levels markedly decreased to basal levels 6 h after
fertilization (Kohoutek et al., 2004). Nevertheless, it was
formally possible that another kinase inhibited by Ros or
BL1 was responsible for initiating EGA. Therefore, we
took an alternative approach to inhibit cyclin A2-CDK2
activity.
We elected to target maternal cyclin A2 mRNA for
destruction prior to its recruitment following fertilization
by an siRNA approach. The advantage of this method is
that, by preventing fertilization-induced cyclin A2 protein
synthesis, activation of CDK2 would be specifically
prevented. RNAi functions in mouse oocytes and preim-
plantation embryos (Svoboda et al., 2001, 2004; Wianny
and Zernicka-Goetz, 1999). Inhibition of CDK2 activation
by cyclin A2 siRNAs was likely very specific, because it
was unlikely that cyclin A2 siRNAs targeted transcripts of
the other members of cyclin family, cyclin A1, E1, E2 and
J, which can associate with CDK2 (Kolonin and Finley,
2000; Lauper et al., 1998; Sweeney et al., 1996). The
analysis for nucleotide sequence of cyclin A2 cording
region, which was used to prepare the siRNAs, revealed
that there was no set of 21 consecutive nucleotides that are
identical between cyclin A2 and the other cyclin family
members. Furthermore, the highest matching was 19 of 21
nucleotides, which was found only in a single site of
cyclin A1 sequence. In other cyclins, we did not find any
Fig. 2. Changes of pronuclear concentration of cyclin A2 during 1-cell stage and the effects of the treatment with 3V-deoxyadenosine (3-dA) and cycloheximide
(CHX). (A) Confocal microscopic images of the mouse 1-cell embryos immunostained with anti-cyclin A2 antibody. One-cell embryos treated with 3-dA, 3V-
deoxyguanosine (3-dG) and CHX were collected 12 h post-insemination (P.I.) and immunostained with anti-cyclin A2 antibody. (B) Relative fluorescence with
an anti-cyclin A2 antibody in the embryos treated with 3-dA and CHX. The average value in the control embryos (12 h, non-treatment) was set as 100%. The
experiment was conducted twice, and similar results were obtained in each case. The numbers of embryo examined were: 32, 29, 19, 27, 15, and 14 for the
control embryos at 6 h, 12 h, and the embryos treated with 3-dA, 3-dG, DMSO, and CHX, respectively. The columns and bars represent mean T SEM. An
asterisk (*) indicates significant difference from the value of the 3-dG (Student’s t test, P < 0.01). Double asterisks (**) indicate significant difference from the
value of the DMSO (Student’s t test, P < 0.01).
Fig. 3. Effects of roscovitine (Ros) and butyrolactone I (BL1) on BrUTP
incorporation by the mouse 1-cell embryos. The embryos were collected 4 h
after insemination and transferred to the culture medium containing Ros or
BL1. DMSO was used as the solvent for Ros and BL1 and the final
concentrations of DMSO in the culture medium were 0.16% and 1.00% for
Ros and BL1, respectively. DMSO and CDK2 inhibitors were not added in
culture medium for the control embryos (treatment minus). The embryos
were collected 12 h after insemination and subjected to in vitro transcrip-
tional activity assay. The average value in the control embryos was set as
100%. The experiments for Ros and BL1 were conducted three times and
twice, respectively. Similar results were obtained in each case. The total
numbers of embryo examined were: 39, 33, 37, 21, and 26 for the control,
Ros, 0.16% DMSO, BL1, and 1% DMSO, respectively. The columns and
bars represent mean T SEM. An asterisk (*) indicates significant difference
from the value of the 0.16% DMSO (Student’s t test, P < 0.01). Double
asterisks (**) indicate significant difference from the value of the 1.00%
DMSO (Student’s t test, P < 0.01).
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nucleotides were matched with those in cyclin A2.
Furthermore, we injected siRNAs rather than dsRNA
because it takes several hours for the dsRNA to be
processed to siRNAs and in our experiment, a relatively
rapid effect of RNAi-mediated mRNA destruction is
required because de novo synthesis of cyclin A2 protein
initiates as early as 6 h after insemination (Figs. 1–4;
Fuchimoto et al., 2001).
Accordingly, we microinjected diced small interference
RNA (d-siRNA), which had been prepared by dicing the
full length of double-strand cyclin A2 mRNA into the MII
eggs; the eggs then inseminated, and 12 h post-insemina-
tion, pronuclear cyclin A2 accumulation and transcriptional
activity were examined. Immunostaining revealed that
microinjection of cyclin A2 d-siRNA markedly decreased
accumulation of cyclin A2 in the pronuclei (Figs. 4A, B).
This effect was specific, because no effect was observed in
accumulation of the TATA binding protein (TBP), whose
concentration in the pronucleus increases after fertilization
(Worrad et al., 1994). Furthermore, microinjection of rabbit
globin d-siRNA did not affect the nuclear accumulation of
cyclin A2. Last, these d-siRNA had little effect on the total
protein synthesis, which was assessed by the incorporation
of [35S]methionine into TCA-precipitated macromolecule
(Supplemental Fig. 2). Coupled with this decrease in
Fig. 4. Inhibition of cyclin A2 accumulation in the nucleus and transcriptional activity by cyclin A2 diced siRNA (d-siRNA). (A) Confocal microscopic images of
the mouse 1-cell embryos immunostained with anti-cyclin A2 antibody (a–c) and anti-TBP antibody (g– i). DNAwas stained with propidium iodide (d– f, j – l).
MII oocytes were microinjected with cyclin A2 d-siRNA (b, e, h, k) or globin d-siRNA (c, f, i, l) and collected 12 h after insemination and immunostained. (B) The
relative intensity of pronuclear fluorescence in the embryos injected d-siRNA. The intensity of fluorescence was measured in the embryos after immunostaining
with anti-cyclin A2 and anti-TBP antibodies. The average value in the control embryos with no injection was set as 100%. The microinjection experiments were
perform three times in which the embryos were immunostained with anti-cyclin A2 antibody and twice with anti-TBP antibody. Similar results were obtained in
each case. The total numbers of embryo examined were: 11, 10, 17, 8, 14 and 11 for control/cyclin A2 immunostain, control/TBP immunostain, globin d-siRNA
injection/cyclin A2 immunostain, globin d-siRNA injection/TBP immunostain, cyclin A2 d-siRNA injection/cyclin A2 immunostain and cyclin A2 d-siRNA
injection/TBP immunostain, respectively. The columns and bars represent means T SEM. An asterisk (*) indicates significant difference from the values of the no
injection and globin d-siRNA injection (Student’s t test, P < 0.01). (C) Effects of the microinjection of cyclin A2 d-siRNA on transcriptional activity in the mouse
1-cell embryos. MII oocytes were microinjected with cyclin A2 d-siRNA or globin d-siRNA, collected 12 h after insemination and subjected to in vitro
transcriptional activity assay. The average value in noninjected embryos was set as 100%. The experiments were conducted three times. Similar results were
obtained in each case. The total numbers of embryos examined were 16, 38, and 35, for no injection, cyclin A2 d-siRNA injection, and globin d-siRNA injection,
respectively. The columns and bars represent mean T SEM. An asterisk (*) indicates significant difference from the values of the no injection and globin d-siRNA
injection (Student’s t test, P < 0.01).
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0.01) in transcriptional activity in embryos microinjected
with cyclin A2 d-siRNA when compared to noninjected
embryos or embryos injected with rabbit globin d-siRNA
(Fig. 4C). These results strongly suggest that cyclin A2
regulates EGA in the 1-cell embryos, presumably via
CDK2, which is cyclin A2’s only known CDK binding
partner during interphase (Sherr, 1996).
Cyclin A2 is essential for progression of S phase in the
somatic cells. It was therefore possible that the reduction of
cyclin A2-CDK2 activity by the CDK inhibitors or micro-injection of cyclin A2 d-siRNA either inhibited entry into S
phase or retarded phase progression, which would lead to
reducing transcription in 1-cell embryos. To address this
possibility, we analyzed the effects of CDK inhibitors and
cyclin A2 d-siRNA on the DNA synthesis in 1-cell embryos.
As shown in Table 1, DNA synthesis was not inhibited by
these treatments; incorporation of BrdU was detected in all
embryos subjected to these treatments, although no incor-
poration was observed in the embryos treated with aphidi-
colin. Furthermore, no difference in the intensity of the BrdU
signal was observed in embryos in any experimental group.
Table 1
Effects of CDK2 inhibitors and the microinjection of diced siRNA on DNA
synthesis in the mouse 1-cell embryos
Treatment No. of experiment No. of embryos
Total analyzed BrdU signal
+ 
No treatment 3 125 125 0
DMSOa 3 85 85 0
Roscovitineb 3 65 65 0
Butyrolactone Ib 3 69 69 0
Globin d-siRNA 2 21 21 0
Cyclin A2 d-siRNA 2 15 15 0
Aphidicolinc 2 12 0 12
a DMSO was added at a concentration of 0.16% or 1.00%, because it was
used as the solvent for roscovitine (Ros) and butyrolactone I (BL1) and the
final concentrations of DMSO were 0.16% and 1.00% for Ros and BL1,
respectively.
b The concentration of Ros and BL1 was 100 AM.
c The concentration of aphidicolin was 3 Ag/ml.
Fig. 5. Effects of cyclin A2-CDK2 protein injection on BrUTP incorpo-
ration in the mouse 1-cell embryos. One-cell embryos were microinjected
with active or heat-inactivated cyclin A2-CDK2 protein, collected 10 h after
insemination and subjected to in vitro transcriptional activity assay. The
average value in the embryos microinjected with inactive cyclin A2-CDK2
protein was set as 100%. The experiments were conducted three times.
Similar results were obtained in each case. The total numbers of embryo
examined were 34 and 29 for inactive protein injection and active protein
injection, respectively. The columns and bars represent mean T SEM. An
asterisk (*) indicates significant difference from the value of the inactive
cyclin A2-CDK2 injection (Student’s t test, P < 0.01).
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these embryos. One-third of the fertilized eggs that had been
microinjected with cyclin A2 d-siRNA remained at the 1-cell
stage 24 h after insemination, whereas more than 90% of the
fertilized eggs that had been microinjected with rabbit globin
d-siRNA cleaved to the 2-cell stage (data not shown). This
inhibition likely reflects the fact that cyclin A2 functions at
G2/M transition, as well as during S phase (Pagano et al.,
1992; Loyer et al., 1994), i.e., during 1-cell stage, cyclin A2
functions as a cell cycle regulator at G2/M transition but not
at S phase. These results demonstrated that cyclin A2-CDK2
appears to regulate EGA by a mechanism independent of the
cell cycle.
To confirm further a role for cyclin A2-CDK2 in
regulating EGA, we microinjected recombinant cyclin A2-
CDK2 protein into 1-cell embryos 1 h after insemination.
The embryos were then cultured, and 10 h after
insemination, they were processed for in vitro transcrip-
tional activity assay. Results of these experiments show
that injection of active cyclin A2-CDK2 protein increased
transcriptional activity by ¨3-fold relative to embryos
injected with heat-inactivated cyclin A2-CDK2 (Fig. 5).
Effects of CDK2 inhibitors and the microinjection of cyclin
A2 diced siRNA on phosphorylation of pRB in the mouse
1-cell embryos
The tacit assumption underlying interpreting the results
of the experiments described above is that cyclin A2-
CDK2 is active in the 1-cell embryo during the time of
EGA. To address this question, we assessed the phosphor-
ylation state of pRB using antibodies specific for pRB
forms that are preferentially phosphorylated by cyclin A2-
CDK2 and the effect of inhibiting this kinase on the state
of pRB phosphorylation.
pRB is phosphorylated on several sites of which Ser249/
Thr252, Thr356, Ser807/811, and Thr821/826 are preferen-tially phosphorylated by cyclin A2-CDK2 (Kitagawa et al.,
1996). Consistent with the increase in nuclear concentration
of cyclin A2 and an increase in cyclin A2-CDK2 kinase
activity following fertilization, phosphorylation of these sites
significantly increased between 6 and 12 h post-insemination
(Figs. 6A, B). The total amount of pRB, which was assayed
with an antibody that recognizes both phosphorylated and
unphosphorylated pRB, was not changed. Nevertheless,
phosphorylation of Ser780, which is the site phosphorylated
by cyclin D/cdk4 but not cyclin A2-CDK2 (Kitagawa et al.,
1996), was not detected in the 1-cell embryos (Fig. 6C).
Following cleavage to the 2-cell stage, a faint signal was
detected in the nucleus at the early 2-cell stage and the signal
intensity was significantly higher by the late 2-cell stage.
To provide additional evidence that the increase in pRB
phosphorylation during 1-cell stage was mediated by CDK2,
1-cell embryos were cultured in the presence of roscovitine.
Results of these experiments demonstrated that phosphory-
lation levels of Ser249/Thr252, Thr356, Ser807/811, and
Thr821/826 were significantly decreased (P < 0.01), but that
total amount of pRB was not changed (Figs. 6A, B). These
results suggested that cyclin A2-CDK2 catalyzed pRB as a
substrate around the time of EGA in the 1-cell embryos.
Nevertheless, it was formally possible that Ros inhibited
another CDK or protein kinase that was responsible for pRB
phosphorylation at these sites. In addition, the contribution
of cyclin A2 synthesized by recruitment of maternal cyclin
A2 mRNA following fertilization was not addressed.
Accordingly, we inhibited CDK2 activity by preventing
accumulation of newly synthesized cyclin A2 protein by
either blocking protein synthesis, or more specifically
destroying cyclin mRNA by siRNAs.
Inhibiting protein synthesis with cycloheximide decreased
phosphorylation of pRB on Ser249/Thr252, Thr356, and
Fig. 6. Phosphorylation of pRB by CDK2 during 1-cell stage. The embryos were incubated with the CZB medium containing roscovitine (Ros) or 0.15%
DMSO. The embryos were collected 6 and 12 h post-insemination (P.I.) and immunostained with the antibodies against pRB (Total), phospho Ser249/Thr252-
pRB (S249/T252), phospho Thr356-pRB (T356), phospho Ser807/811-pRB (S807/811), and phospho Thr821/826-pRB (T821/826). (A) Confocal microscopic
images of the mouse 1-cell embryos immunostained with anti-pRB antibody or site-specific anti-phospho pRB antibodies. (B) The relative intensities of
pronuclear fluorescence in the embryos immunostained with anti-pRB antibody and site-specific anti-phospho pRB antibodies. The average value in the
embryos treated with DMSO was set as 100%. The experiments for phospho S249/T252, T356, and S807/811-pRB were conducted three times, and those for
phospho T821/826 and total pRB were twice. Similar results were obtained in each case. Eight or more embryos were analyzed in any experimental groups.
The columns and bars represent mean T SEM. Asterisks (*) indicate significant differences from the values of the 6 h P.I. and Ros (Student’s t test, P < 0.01).
(C) Confocal microscopic images of the mouse embryos immunostained with anti-Ser780-pRB antibody (S780). DNAwas stained with propidium iodide. One-
cell embryos, early 2-cell, and late 2-cell embryos were collected 12, 19, and 30 h P.I., respectively, and immunostained with anti-S780-pRB antibody. The
experiment was conducted three times. Similar results were obtained in each case.
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Likewise, injecting cyclin A2 d-siRNA resulted in a marked
reduction in Thr356 phosphorylation (Fig. 7). This effect
was specific, because it was not observed when rabbit
globin d-siRNA was injected (Fig. 7). Moreover, injection
of recombinant cyclin A2-CDK2 protein 1 h after insemi-
nation resulted in a substantial increase in Thr356 pRB
phosphorylation determined 6 h post-insemination as
determined by immunocytochemistry (Fig. 8). This effect
was not observed when heat-inactivated protein was
injected. In toto, results of these experiments indicate that
cyclin A2 mRNA recruited following fertilization leads to
activation of CDK2.Discussion
Once EGA initiates, expression of factors involved in
transcription could sustain and augment transcription.Nevertheless, initiation of EGA must depend on molecules
that are maternally inherited; sperm-derived factors are not
involved because EGA occurs in parthenogentically ac-
tivated eggs. The identity of such factors, however, has
remained elusive. The results described here, using a
combination of approaches to inhibit or increase CDK2
activity, provide new insights regarding the molecular
basis for EGA initiation following fertilization, namely,
recruitment of maternal cyclin A2 mRNA following
fertilization leads to activation of CDK2 that in turn
participates in EGA. It is unlikely that cyclin E binds to
and activates CDK2, as in somatic cells (Sherr, 1996), to
initiate EGA, because cyclin E is not detected in the
mouse 1-cell embryos by immunoblotting (Naito K.,
unpublished data).
The mechanistic linkage between CDK2 activation by
complexing with newly synthesized cyclin A2 and EGA,
however, is not resolved. Nevertheless, there are a number of
reports demonstrating that cyclin A2-CDK2 can regulate
Fig. 8. Effects of cyclin A2-CDK2 protein microinjection on phosphory-
lation of Thr356 on pRB in the mouse 1-cell embryos. One-cell embryos
were microinjected with active or heat-inactivated cyclin A2-CDK2 protein
at 1 h after insemination. They were collected 6 h post-insemination and
subjected to immunostaining with anti-Thr356-pRB antibody. The average
value in the embryos microinjected with inactive cyclin A2-CDK2 protein
was set as 100%. The experiments were conducted three times and similar
results were obtained in each case. The total numbers of embryos examined
were 18 and 24 for inactive protein injection and active protein injection,
respectively. The columns and bars represent mean T SEM. An asterisk (*)
indicates significant difference from the value of the inactive cyclin A2-
CDK2 injection (Student’s t test, P < 0.01).
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activate a transcription factor. Several reports demonstrate
that general transcription factor Sp1 can associate with and
be phosphorylated by cyclin A2-CDK2 (Fojas de Borja et al.,
2001; Haidweger et al., 2001). Phosphorylation of Sp1
increases its DNA binding affinity (Fojas de Borja et al.,
2001; Haidweger et al., 2001) and hence could stimulate
transcription. Sp1 binding sites, the GC box and the related
GT/CACC box are present in many promoters and other
regulatory sequences of tissue-specific and ubiquitous genes
(Philipsen and Suske, 1999), suggesting that cyclin A2-
CDK2 regulates expression of numerous genes via regulat-
ing Sp1 activity. Of note is that the amount of phosphory-
lated Sp1 increases during the 1-cell stage (Worrad and
Schultz, 1997).
pRB is also a substrate for CDKs (Sherr, 1996) and
pRB phosphorylation is known to modulate transcription
(Harbour and Dean, 2000a,b; Nevins et al., 1997;
Swanton, 2004; Vandel et al., 2001). pRB can interact
with the transcription activation domain of members of
the E2F transcription factor family, which modulate the
expression of many genes, and thereby inhibit their
activity. In addition, pRB can interact with enzymes
involved in chromatin remodeling such as histone
deacetylases (HDACs). Such an interaction could also
lead to repression of transcription. pRB phosphorylation
leads to dissociation of pRB from E2F members or
release of HDAC, each of which will relieve repression
of that particular promoter. Cyclin A2-CDK2 can
phosphorylate pRB and results of experiments reported
here strongly implicate cyclin A2-CDK2 phosphorylatingFig. 7. Effects of cyclin A2 d-siRNA microinjection on the phosphory-
lation of Thr356 on pRB in the mouse 1-cell embryos. MII stage oocytes
were microinjected with mouse cyclin A2 d-siRNA or rabbit alpha-globin
d-siRNA. Twelve hours after insemination, they were immunostained with
anti-Thr356-pRB antibody. The average value in the control embryos with
no injection was set as 100%. The experiments were conducted twice and
similar results were obtained in each case. The total numbers of embryos
examined were 11, 9, and 10 for no injection, cyclin A2 d-siRNA
injection, and globin d-siRNA injection, respectively. The columns and
bars represent mean T SEM. An asterisk (*) indicates significant difference
from the values of the no injection and globin d-siRNA injection (Student’s
t test, P < 0.01).pRB in the 1-cell embryo during a time consistent with
this kinase being involved in EGA, perhaps through the
mechanisms described above. Of interest is that an
increase in histone acetylation occurs during the time of
EGA (Adenot et al., 1997). Current experiments are
addressed at determining direct targets of cyclin A2-
CDK2 that are involved in initiating EGA.
Last, our finding may provide insight into the mecha-
nism for the dramatic reprogramming in gene expression
that accompanies EGA with the conversion of a highly
differentiated oocyte into totipotent blastomeres. The tran-
scription machinery in the embryo prior to EGA is of
maternal origin. So how can EGA lead to dramatic changes
in gene expression? By recruiting a maternal mRNA, i.e.,
cyclin A2, the embryo is able to up-regulate expression of
a protein during this transition. And by up-regulating
synthesis of cyclin A2, which as described above can
modulate the function of proteins involved in expression of
a large number of genes, a reprogramming of gene
expression may ensue.Acknowledgments
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